Thryv Therapeutics Inc.
Team Leader
Team Staff
About Thryv
Thryv Therapeutics is a Canadian biotechnology company focused on developing precision medicine treatments for serious cardiovascular conditions. The company is advancing research into potent and selective inhibitors of Serum Glucocorticoid-inducible Kinase 1 (SGK1) to target diseases such as congenital Long QT Syndrome, atrial fibrillation, and heart failure. Its work includes clinical studies and a pipeline aimed at novel therapeutic approaches to improve outcomes for patients with these cardiac disorders.
Contact
Thryv Therapeutics Inc.
999 Blvd. De Maisonneuve West, Suite 1250
Montreal, Quebec
Canada
Visit websiteMontreal, Quebec
Canada
Manage Cookie Consent
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.
The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.